Home

Élaborer profondément Installer ardelyx press release la tour Au plus tôt sauvetage

Ardelyx
Ardelyx

Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Poster  Presentations on XPHOZAH®…
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Poster Presentations on XPHOZAH®…

🦍💎 $ARDX ✋🚀
🦍💎 $ARDX ✋🚀

Scripts : r/ARDELYX
Scripts : r/ARDELYX

SEC Filing | Ardelyx, Inc.
SEC Filing | Ardelyx, Inc.

ARDX / Ardelyx, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options  Activity
ARDX / Ardelyx, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options Activity

Ardelyx Announces Proposed Public Offering of Common Stock
Ardelyx Announces Proposed Public Offering of Common Stock

Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases |  FinancialContent Business Page
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page

Ardelyx on X: "Press Release: FDA Grants Appeal for Ardelyx's XPHOZAH®  (tenapanor) Read more here: https://t.co/drMd3jYvKl  https://t.co/DYmGNsa9Nt" / X
Ardelyx on X: "Press Release: FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor) Read more here: https://t.co/drMd3jYvKl https://t.co/DYmGNsa9Nt" / X

FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor  Fitzgerald - MarketBeat
FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor Fitzgerald - MarketBeat

AFTER HOUR TRADING IS HALTED : r/ARDELYX
AFTER HOUR TRADING IS HALTED : r/ARDELYX

Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces $20 Million  Financing Agreement with…
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces $20 Million Financing Agreement with…

Ardelyx
Ardelyx

Ardelyx to Raise $110 Million in a Private Placement
Ardelyx to Raise $110 Million in a Private Placement

Hyperphosphatemia Pipeline Insight Report 2023 (Updated)
Hyperphosphatemia Pipeline Insight Report 2023 (Updated)

Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF |  Chronic Kidney Disease | Therapy
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF | Chronic Kidney Disease | Therapy

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ardelyx, Inc.  (ARDX) Investigation
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ardelyx, Inc. (ARDX) Investigation

Ardelyx
Ardelyx

Ardelyx wins FDA approval for phosphate absorption inhibitor -  Pharmaceutical Technology
Ardelyx wins FDA approval for phosphate absorption inhibitor - Pharmaceutical Technology

Ardelyx: Q3 Earnings Snapshot -October 31, 2023 at 07:30 am EDT |  MarketScreener
Ardelyx: Q3 Earnings Snapshot -October 31, 2023 at 07:30 am EDT | MarketScreener

ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc.  on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the  Firm | Business Wire
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm | Business Wire

Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?
Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?

Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review

Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review

Ardelyx, Inc. (NASDAQ:ARDX) Q3 2023 Earnings Call Transcript
Ardelyx, Inc. (NASDAQ:ARDX) Q3 2023 Earnings Call Transcript

Positive FDA AdCom votes for Ardelyx's tenapanor
Positive FDA AdCom votes for Ardelyx's tenapanor

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. |  Internet | Biotech Stock Review
And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. | Internet | Biotech Stock Review